Biosimilars Poised to Drive Down Treatment Costs in Oncology
Published: Monday, Dec 23, 2019
Julie R. Gralow, MD
With several biosimilars approved by the FDA, these agents are now beginning to be used in clinical practice in place of the reference products, explained Julie R. Gralow, MD.
... to read the full story